Omnia Wellness Expands its Endo-Kinetic Treatment into the $18 Billion Chiropractic Industry with its first BodyStop Express™
DENVER, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Omnia Wellness Inc. (the “Company”) (OTC US: OMWS), a health and wellness company commercializing advanced therapeutic technologies, announced today that it has partnered with Terlep Chiropractic, founded by Dr. Timothy Terlep, to offer its proprietary SolaJet Dry-Hydrotherapy, and feature its Endo-Kinetic treatment into the medical wellness market segment through its first BodyStop Express™ location. This agreement is the first of several partnerships the Company expects to secure as it broadens and diversifies its customer base in the medical wellness market.
Company partners with medical private practices due to growth in demand for a holistic approach to medical wellness
Seasoned professional in chiropractic medicine, Dr. Timothy Terlep, implements first BodyStop Express™ into his private practice
DENVER, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Omnia Wellness Inc. (the “Company”) (OTC US: OMWS), a health and wellness company commercializing advanced therapeutic technologies, announced today that it has partnered with Terlep Chiropractic, founded by Dr. Timothy Terlep, to offer its proprietary SolaJet Dry-Hydrotherapy, and feature its Endo-Kinetic treatment into the medical wellness market segment through its first BodyStop Express™ location. This agreement is the first of several partnerships the Company expects to secure as it broadens and diversifies its customer base in the medical wellness market.
Omnia’s SolaJet products incorporate a hands-free approach proven to treat soft tissue ailments and have been instrumental in increasing Dr. Terlep’s patients’ satisfaction as well as the financial performance of his practice. The proprietary suite of Endo-Kinetic treatment products allow for a unique and novel holistic wellness experience that provides immediate results. Dr. Terlep is also a consultant to Omnia Wellness as his knowledge in chiropractic and medical applications is in invaluable.
“We are looking forward to leveraging Dr. Terlep’s expertise in managing a chiropractic practice and knowledge of working with patients in pain to assist our business as we seek to expand our reach and gain market share in the growing $18 billion chiropractic industry. Dr. Terlep is highly respected as an expert in chiropractic services, who has for many years, successfully used the Endo-Kinetic treatment approach at his own practice. We are also excited about the opportunity to introduce our hands-free Endo-Kinetic treatment products to a larger and more diverse customer base within the medical wellness market,” said Steve Howe, Omnia Wellness Executive Chairman.
According to ResearchandMarkets, the U.S. chiropractic market size is expected to reach $17.9 billion by 2025. The rising cases of back, shoulder, foot, neck pain, and headaches are driving the chiropractic market in the U.S. and are expected to be the main driver of the revenue generation. Additionally, chiropractic practices have also seen a steady increase in the acceptance by doctors, third-party payers, and the federal government apart from patients, which is an important component to support the market expansion. American Chiropractic Association has estimated that by end of 2021, there will be over approximately 80,000 chiropractors in the country, with an addition of over approximately 2,500 new practitioners graduating from colleges, who are expected to treat about 35 million patients each year. Moreover, the market is driven by increasing number of patients seeking complementary medical treatments rather than approved medicine.
About Dr. Timothy Terlep
Dr. Terlep, founder of Terlep Chiropractic in Spring Hill, Florida has practiced chiropractic medicine for 25 years. Post-doctoral studies in functional neurology became an area of extensive training and a focus of care through the years. Dr. Terlep has maintained a commitment to a focus on the causes and correction of the many conditions which his practice sees as well as bringing relief from the symptoms which those conditions create. With the acceleration of advanced technologies in the last many years, incorporating those technologies to accelerate healing and improve clinical specificity has been a passion of Dr. Terlep. It is due to this passion the office utilizes the most advanced diagnostic and therapeutic tools available. He is actively involved with the local medical community and is also a member of the Florida Chiropractic and American Chiropractic Associations. He completed his undergraduate education at Indiana University and received graduate training at the renowned Palmer College of Chiropractic and his doctoral degree in 1988.
About Omnia Wellness Inc.
Omnia Wellness Inc. is an innovative developer of a disruptive dry-hydrotherapy technology for massage, fitness, and medical applications. Through its subsidiaries Omnia Wellness Inc. and Solajet® Financing Company, Omnia Wellness expects to commercialize SolaJet’s Dry-Hydrotherapy, Endo-Kinetic™ technology, which provides deep tissue suppression, therapeutic heat, vibration, and a flushing full-body “wave” combining four therapies in one. Treatments are designed to deliver the feeling similar to an hour-long traditional massage in as little as 15 minutes at an affordable price point for the consumer. In response to COVID-19, the Company is emphasizing its technology as “touchless” therapy. It is the expectation of Omnia Wellness to create a national chain of “BodyStop® Relaxation and Therapeutic Centers,” with the first BodyStop® expected to open in the fourth quarter of 2021, and “BodyStop® Recovery Zones,” which are expected to be made available at fitness clubs.
Forward-Looking Statements
This press release may contain “forward-looking statements”, including but not limited to: statements regarding the Company’s overall business; total addressable market; and expectations regarding future sales and expenses. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these as forward-looking statements. Moreover, forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to successfully implement training programs for the use of its products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to develop sales for its new product solutions; the acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense, and time associated with sales; the lengthy evaluation and sales cycle for the Company’s products; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the business impact of health crises or outbreaks of disease, such as epidemics or pandemics; the ability to obtain export licenses for countries outside the U.S.; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company’s ability to maintain and enhance its brand, as well as other risk factors. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, or changes in its expectations.
Attachment
Contact: Email: [email protected] Tel: 888-320-5711
